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bidmedical conditions. Dr. Katon's work revolutionized the care of psychiatric illnesses in primary care and other
medical care settings to the beneﬁt of countless patients worldwide.external funding.
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Few researchers have had as profound an impact on science in the
ﬁeld of psychosomatic medicine as Dr. Wayne Katon. He began his re-
search career at a time when our ﬁeld had just begun to recognize
that the majority of patients with psychiatric illnesses were not receiv-
ing any treatment [1], and that more than half of all treatment for psy-
chiatric illnesses was provided in primary care settings rather than by
psychiatrists in specialty mental healthcare settings [2]. However, little
rigorous research was available on the epidemiology of common psy-
chiatric illnesses presenting in primary care and other nonpsychiatric
medical settings. Further, almost no evidence-based interventions
were available to effectively address psychiatric illnesses within these
healthcare settings [3].Over the course of his career, Dr. Katon and his research team revo-
lutionized this ﬁeld of research. In his over 35 years as a member of the
faculty of the Department of Psychiatry and Behavioral Sciences at the
University of Washington, he published over 500 articles, many of
them highly cited. His research team and he were awarded numerous
National Institutes of Health grants, and he established a Division of
Health Services and Psychiatric Epidemiology at the University of
Washington that became internationally renowned for its research [4].
Festschrift is a German word referring to a tradition in academia
where a respected academic is honored with a tome reviewing their ac-
ademic career and accomplishments, generally presented to them by
their colleagues, mentees and trainees upon retirement [5]. When
such a publication is compiled posthumously, it is referred to as a
Gedenkschrift [5] and serves as a lasting memorial.
Few scholars in psychosomatic medicine would be more worthy of a
Festschrift than Dr. Katon. Sadly, Dr. Wayne Katon passed away on
March 1, 2015 at the age of 64 after a long battle with lymphoma, active
and engaged with his many colleagues and friends to the day of his un-
timely death. The current paper is a Gedenkschrift honoring his proliﬁc
academic career. In addition to memorializing Dr. Katon's scholarly
work and honoring his legacy, an important objective of this paper is to
review the landmark epidemiological and interventional studies that he
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in this review include: (a) howDr. Katon’s clinicalwork andobservational
epidemiology and health services research informed his intervention
studies; (b) the evolution of the interventional trials conducted by his re-
search team from primary care-based psychiatric consultation to primary
care-based collaborative care for depression to multicondition collabora-
tive care; and (c) how Dr. Katon's research has informed the academic
work of other leading researchers in the ﬁeld of psychosomatic medicine.
In order to complete this Gedenkschrift, we reviewed the abstracts
of all 547 Medline citations authored or coauthored by Dr. Katon (as
of June 28, 2015). We identiﬁed articles presenting original epidemio-
logical research and/or the results of interventional trials as well as re-
view papers of importance to the foundation of original research
authored or coauthored by Dr. Katon. We included articles in this
Gedenkschrift that were deemed seminal in the ﬁeld of psychosomatic
medicine by consensus of all authors. In addition, the ﬁrst author
(DSD) solicited additional information from coauthors who collaborat-
ed with Dr. Katon regarding key aspects of the background of important
studies. In addition,we reviewed landmark studies directly informed by
Dr. Katon's work conducted by his mentees and/or colleagues.
As points of reference, the paper is organized chronologically. Papers
presenting the results of key epidemiological and interventional studies
authored or coauthored by Dr. Katon are summarized in Tables 1 and 2.
2. Depression, somatization and the emergence of primary care psy-
chiatry (1980–1995)
Dr. Katon's initial academicwork focused on understanding the rela-
tionship of somatization with depression and on increasing awareness
by nonpsychiatric physicians that patients with depression often pres-
ent with somatic symptoms. This research, initiated under the mentor-
ship of Dr. ArthurKleinmanat theUniversity ofWashington,was largely
shaped byDr. Katon's clinicalwork as a consultation–liaison psychiatrist
[6]. In a two-part review published in 1982, Drs. Katon, Kleinman and
Dr. Gary Rosen highlighted the interrelationship of somatization and
major depression and misdiagnosis of major depression in primary
care settings [7,8]. This reviewwas followed by several important obser-
vational studies highlighting the key role that psychiatric illnesses such
asmajor depression and panic disorder play in somatization and specif-
ic patient presentations such as noncardiac chest pain, chronic pain,
chronic fatigue syndrome (CFS) and unexplained dizziness [9–18].
This epidemiologicalwork laid the foundation forwhatwould become
the renownedDivision ofHealth Services and Psychiatric Epidemiology at
the University of Washington Department of Psychiatry and Behavioral
Sciences. A cornerstone of this division was a T32-funded National Re-
search Service Award, initially funded by Health Resources and Services
Administration and later funded by National Institute of Mental Health,
that Dr. Katon obtained for the purpose ofmentoring and training psychi-
atrists and primary care physicians (PCPs) in epidemiology and health
services research methodology. With the support of this training grant,
which has been continuously funded for over 25 years, Dr. Katon
mentored an entire generation of clinical health services researchers at
the University of Washington, many of whom, such as Drs. Lydia
Chwastiak, Paul Ciechanowski, Charles Engel, Jesse Fann, Laura Richard-
son, Mark Sullivan, Jürgen Unützer, Edward Walker and Douglas Zatzick,
would go on to exceptional research careers of their own.
Informed by his initial epidemiological studies and his clinical work
consulting in a busy primary clinic, Dr. Katon began a research collabora-
tionwith Dr. Michael Von Korff, a health service researcher and epidemi-
ologist, andDr. Elizabeth Lin, a PCP and health services researcher, both at
GroupHealth Research Institute (GHRI) in Seattle,WA, USA. Little did the
three of them know at the time that their collaboration would span four
decades and not just revolutionize psychosomatic medicine but also the
care of psychiatric illnesses in general healthcare settings worldwide.
Based on their ﬁndings regarding the high prevalence of major de-
pression and unmet mental healthcare need in primary care [19],Drs. Katon, Von Korff and Lin, along with Dr. Edward Wagner of the
GHRI, the father of the chronic care model [20], designed an initial ran-
domized controlled trial (RCT) of psychiatric consultation in primary
care [21]. The rationale for this initial trial was that primary care-based
psychiatric consultationwould increase PCP awareness of psychiatric ill-
nesses and their role in driving care utilization, improve PCPs' psychiatric
diagnostic capabilities and ultimately lead to improved treatment of psy-
chiatric conditions, particularly depression, in primary care settings [21].
In 1992, Drs. Katon, Von Korff, Lin et al. published the results of this
RCT [21]. While patients randomized to the psychiatric consultation in-
tervention were signiﬁcantly more likely to be prescribed an antide-
pressant, and over the course of trial, PCPs were more likely to
prescribe antidepressant medications, the intervention had no signiﬁ-
cant effects on patients' psychiatric symptoms or healthcare utilization
[21]. The team was able to show that improvement in depression was
associated with signiﬁcantly fewer disability days over the course of a
1-year follow-up (f/u) [22], but the intervention itself did not improve
disability outcomes.
This “negative” trial was the basis for several important insights
about the treatment of depression by Dr. Katon and his research team.
In particular, improved recognition of psychiatric illness and initiation
of treatment were insufﬁcient by itself. The team recognized that pa-
tients with major depression and other psychiatric illnesses require on-
going monitoring for medication adherence to ensure adequate trials
and timely therapeutic response to optimize beneﬁts of treatment
when initially prescribed treatments are not effective [21]. Furthermore,
the addition of behavioral components to a primary care-based psychi-
atric interventionmay be needed in order to facilitate patient adherence
with treatment [21].
3. From psychiatric consultation to collaborative care (1995–2004)
With the lessons learned from the psychiatric consultation in prima-
ry care RCT in hand, Drs. Katon, Lin, Von Korff et al. designed a new pri-
mary care-based mental health intervention. The team integrated the
systems-based approaches of the chronic care model [20] and shifted
focus from recognition and diagnosis of psychiatric illnesses to ensuring
that primary care patients with major depression were adequately
treated over time through multidisciplinary team-based care so that
full therapeutic beneﬁt could be achieved in the primary care setting.
Rather than focusing on distressed high utilizers of primary care, they
sought to improve depression care and depressive symptoms through
increased collaboration between the consulting psychiatrist and PCP
to achieve guideline-level antidepressant treatment and track patient ad-
herence to depression treatment. A key component of the intervention
was alternating patient visits with the PCP and a primary care-based psy-
chiatric consultant after initiating antidepressant therapy to ensure ade-
quate monitoring of outcomes and adjustment of therapy when
adequate clinical response was not achieved. The research team was
joined in this new RCT by Dr. Gregory Simon, a psychiatrist at GHRI, and
Dr. Edward Walker, a psychiatrist at the University of Washington.
In 1995, the team published the results of the trial in an article enti-
tled, “Collaborative Management to Achieve Treatment Guidelines: Im-
pact on Depression in Primary Care,” in the Journal of the American
Medical Association (JAMA) [23]. This publication documented the
ﬁrst large-scale RCT of what would come to be known as collaborative
care. They reported that not only were intervention patients with
major depression signiﬁcantly more likely to be adherent to guideline-
level doses of antidepressants and to be more satisﬁed with their de-
pression care, theywere also signiﬁcantlymore likely to have a clinically
signiﬁcant (i.e., ≥50%) reduction in depressive symptoms over the
course of f/u [23].
Dr. Katon et al. followed-up this report with a second trial in which
addition of a primary care-based brief psychotherapy component deliv-
ered by a psychologist, Dr. Evette Ludman, of the GHRI, led to reductions
in depressive symptoms and increased treatment adherence [24]. This
Table 1
Summary of selected articles authored or coauthored by Wayne Katon reporting important epidemiological and health services ﬁndings.
Study type Setting, population
and N
Follow-
up
period
(months)
Exposure(s) of interest Outcome(s) of interest Key ﬁndings
Somatic symptom studies
Katon et al.
1984 [9]
Case–control 261 medical–surgical
inpatients (100 w/
somatization and 161
w/o somatization
n/a DSM-III diagnoses Somatization Major depression and personality
disorders were signiﬁcantly more
common in somatizing patients.
Only 1/3 of somatizing patients
had DSM-III somatoform
disorder diagnoses.
50% of somatizing patients
prescribed opioids and/or
sedative-hypnotics.
Katon et al.
1991 [14]
Cross-sectional 119 primary care patients
with high care utilization
n/a Number of medically
unexplained somatic
symptoms
DSM-III-R
diagnoses
Somatization disorder Patients with 4–12 medically
unexplained somatic symptoms
had a consistent and substantial
level of functional impairment.
Number of lifetime and current
psychiatric diagnoses signiﬁcantly
associated with increased number
of medically unexplained somatic
symptoms.
Katon et al.
1992 [16]
Cross-sectional 285 patients with CFS n/a Number of lifetime
physical symptoms
Lifetime prevalence of
DSM-III-R depressive
and anxiety disorders
Increasing number of lifetime
physical symptoms in CFS patients
associated with signiﬁcantly higher
prevalence of lifetime and current
major depression and/or
anxiety disorders.
Primary care–psychiatry epidemiology
Katon et al.
1990 [19]
Cross-sectional 119 primary care patients
with high care utilization
n/a n/a Prevalence of DSM-III
diagnoses
Mental health treatment
needs
Two-thirds with lifetime major
depression and 80% with current
axis I disorder (of which current
major depression was most common).
One-third were previously
undiagnosed, and 2/3 had unmet
mental health treatment needs.
Von Korff et al.
1992 [22]
Longitudinal
cohort
143 primary care patients
with high care utilization
6, 12 Improvement in
depression
Number of disability
days
Improvement in depressive symptoms
from baseline was associated with a
signiﬁcant reduction in disability days.
Holliﬁeld et al.
1997 [31]
Case–control 123 primary care patients
(62 w/ panic disorder and
61 w/o panic disorder)
n/a Major depression
Neuroticism
Chronic medical illness
Demographics
HRQOL Patients with panic disorder reported
signiﬁcantly worse HRQOL vs. patients
without panic disorder.
Comorbid major depression was
single factor most strongly associated
with worse self-reported HRQOL.
Unützer et al.
1997 [35]
Prospective
cohort
2558 primary care
patients
≥65 years old
24, 48 Depressive symptoms Ambulatory medical
costs
Increasing depressive symptom
severity independently associated
with signiﬁcantly higher ambulatory
medical costs at 2 and 4-year follow-
up.
Walker et al.
2003 [34]
Retrospective
cohort
1225 female primary care
patients
60 PTSD symptoms Total healthcare costs
(i.e., ambulatory and
inpatient medical and
mental health costs)
Compared to women with no or low
levels of PTSD symptoms, moderate
PTSD symptoms were associated
with a 38% increase in total
healthcare costs while severe PTSD
symptoms were associated with a
104% increase in total healthcare costs.
Epidemiology of depression and diabetes
Ciechanowski
et al. 2000
[42]
Prospective
cohort
367 primary care patients
with diabetes
6 Depressive symptoms Diabetes treatment
adherenceHRQOL
Healthcare costs
Moderate-to-severe depressive
symptoms in patients with diabetes
independently associated with poorer
diabetes treatment adherence, worse
physical and mental HRQOL
and higher healthcare costs.
Katon et al.
2004 [46]
Cross-sectional 4225 primary care
patients
with diabetes
n/a Comorbid major
depression
CVD risk factors Comorbid major depression
independently associated with
1.5 to 2.0-times greater odds of
≥3 CVD risk factors.
Comorbid major depression
independently associated with
smoking, obesity, sedentary
lifestyle and HbA1c ≥8.0 in patients
w/o known CVD.
(continued on next page)
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Table 1 (continued)
Study type Setting, population
and N
Follow-
up
period
(months)
Exposure(s) of interest Outcome(s) of interest Key ﬁndings
Comorbid major depression
independently associated with
obesity, sedentary lifestyle and
triglycerides ≥400 in patients
without known CVD.
Katon et al.
2005 [50]
Prospective
cohort
4154 primary care
patients
with diabetes
36 Comorbid major or
minor depression
All-cause mortality Comorbid major depression
independently associated with
2.30-times greater risk of mortality
and comorbid minor depression
independently associated with
1.67-times greater risk of mortality.
Lin et al.
2010 [49]
Prospective
cohort
4623 primary care
patients
with diabetes
60 Comorbid major
depression
Microvascular and
macrovascular
complications of diabetes
Comorbid depression independently
associated with 1.36-times greater
risk of microvascular complications
and 1.24-times greater risk of
macrovascular complications
of diabetes.
Katon et al.
2010 [57]
Prospective
cohort
3837 primary care patients
with diabetes
60 Comorbid major
depression
Dementia Comorbid major depression in
patients with diabetes independently
associated with 2.69-times greater
risk of incident dementia.
Katon et al.
2012 [58]
Prospective
cohort
19,239 primary care
patients with diabetes
60 Comorbid major
depression
Dementia During years 3 through
5 postbaseline, comorbid major
depression in patients with diabetes
independently associated with
2.02-times greater risk of
incident dementia.
Katon et al.
2015 [60]
Longitudinal
cohort
2.4 million Danish citizens
≥50 years old
84 Depression Diabetes
Comorbid depression
and diabetes
Dementia Depression alone associated with
1.83-times greater risk of incident
dementia.
Diabetes alone associated with
1.20-times greater risk of
incident dementia.
Comorbid depression and diabetes
associated with 2.17-times greater
risk of incident dementia.
Among individuals
b65 years old, comorbid depression
and diabetes accounted for 25%
of incident dementia cases.
Epidemiology of depression and pregnancy outcomes
Grote et al.
2010 [67]
Meta-analysis
of prospective
studies
29 studies including
48,004 women
n/a Antenatal depression PTB
LBW
IUGR
Antenatal depression associated
with signiﬁcantly increased risk of
all three adverse birth outcomes.
The association of antenatal
depression and LBWwas stronger
in studies conducted in developing
countries compared to those in the
US or Europe.
Antenatal depression associated
with increased risk of PTB in US
women of lower SES.
Melville et al.
2010 [66]
Cross-sectional 1888 women receiving
prenatal care
n/a Demographics
Psychosocial
stressChronic medical
comorbidity
Domestic violence
Antenatal major or
minor depression
10% of women had major (5%) or
minor (5%) depression. Current
suicidal ideation was present in
29% of women with major depression.
Psychosocial stress, domestic
violence, chronic medical conditions,
and Asian-American or African-
American race independently
associated with increased odds of
antenatal major depression.
Epidemiology of pediatric depression
Richardson
et al.
2004 [61]
Prospective
cohort
1205 Medicaid-covered
children 5–18 years old
seen in primary care with
incident depression,
of whom 507 (42%)
were prescribed an
antidepressant
6 Antidepressant
prescription
Number of follow-up
visits with a provider
Continuation of
antidepressant at 3 and
6 months after initial
prescription
Only 28% of youth prescribed an
antidepressant had ≥3 months in
the next 3 months, while 29% had
no follow-up visits.
SSRIs were continued by 47% youth
at 3 months and 26% at 6 months.
Having ≥3 provider f/u visits after
initial antidepressant prescription was
associated with 2.02-times greater
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Table 1 (continued)
Study type Setting, population
and N
Follow-
up
period
(months)
Exposure(s) of interest Outcome(s) of interest Key ﬁndings
odds of medication continuation
at 3 month study f/u.
Katon et al.
2010 [63]
Cross-sectional 2291 teenagers
ages 13–17 seen in
primary care
n/a Possible major
depression (PHQ-2≥3)
Obesity and physical
activity
Substance abuse
Interactions with parents
and peers
Self-rated general
health
Possible major depression was
associated with signiﬁcantly
increased odds of obesity, limited
physical activity, problems with
schoolwork, difﬁculties in
relationships with parents and
their peers, poor self-rated general
health and substance abuse.
Abbreviations (in alphabetical order): CVD = cardiovascular disease; DSM-III = Diagnostic and Statistical Manual of Mental Disorders, Third Edition; DSM-III-R = DSM, Third Edition,
Revised; f/u = follow-up; IUGR = intrauterine growth restriction; LBW= low birth weight; n/a = not applicable; PHQ-9 = Patient Health Questionnaire-9; PTB = preterm birth; SES =
socioeconomic status; SSRIs = selective serotonin reuptake inhibitors.
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patients in care, an approach that became a hallmark of collaborative care
interventions. The team found thatwhile the primary care-based collabo-
rative care intervention increased the cost of depression care overall (pri-
marily due to the increased number of patient visits), the intervention
was cost-effective among patients with major depression [25].
Capitalizing on the success of the initial collaborative care trials,
Dr. Katon et al. conducted a f/u randomized trial adding an additional
component to the original treatment paradigm, “stepped care,” in
order to reﬂect the growing reality that more patients with depression
were being started on antidepressants by their PCPs, and many might
need subsequent increases in intensity of care to improve [26]. In this
trial, primary care patients with persistent depression after being
started on an antidepressant by their PCP 6–8 weeks prior were ran-
domized into a collaborative care intervention in which intervention
patients were seen by a primary care-based psychiatrist for at least
two visits, that is, a “stepped-up” level of care [26]. The intervention
also included other components utilized in their initial collaborative
care RCT. This f/u trialwas also successful, showing that the stepped col-
laborative care intervention led to symptomatic improvement and
greater likelihood of remission of the depressive episode [26].
Subsequently, the team conducted an f/u trial utilizing two inperson
visits with primary care-based depression care managers trained by
Drs. Katon, Lin and Ludman with the aim of preventing major depres-
sive episode recurrence [27].While the intervention did not prevent re-
currence of major depression, it did improve antidepressant adherence
and reduced depressive symptomburdens [27]. In the same year, the re-
sults of an RCT, led by Dr. Peter Roy-Byrne of the University of
Washington with close collaboration from Dr. Katon, which adapted
collaborative care for panic disorder in primary care, were released
[28]. This RCT found that a primary care-based collaborative care ap-
proach reduced severity of panic symptoms and signiﬁcantly improved
health-related quality of life (HRQOL) [28]. A subsequent cost-
effectiveness analysis of this trial showed that the collaborative care inter-
vention did not signiﬁcantly increase outpatient healthcare costs versus
usual care and that intervention patients experienced signiﬁcantly more
anxiety free days [29]. In an another RCT, Dr. Douglas Zatzick of the Uni-
versity of Washington, under the mentorship of Dr. Katon, showed that
an acute care-based collaborative care intervention for posttraumatic
stress disorder (PTSD) and problem drinking following traumatic injury
reduced PTSD symptoms and problem drinking behaviors [30].
At the same time that Dr. Katon was becoming world renowned for
pioneering primary care-based collaborative care for depression, he
coauthored a series of important studies on the clinical epidemiology
of commonmental disorders in primary care with his mentees and col-
leagues. These works included coauthored papers such as a report
authored by Dr. Michael Holliﬁeld identifying signiﬁcantly worse
HRQOL among patients with panic disorder [31], one authored byDr. Mark Sullivan detailing worse long-term physical functioning
among coronary artery disease (CAD) patientswith depressive and anx-
iety symptoms [32] and two reports authored by Dr. Edward Walker,
the ﬁrst documenting the ﬁndings of a study highlighting signiﬁcantly
increased healthcare costs among female primary care patients with a
history of childhood abuse or neglect [33] and a second f/u study iden-
tifying similarly increased healthcare costs among female primary care
patientswith PTSD [34].With Dr. JürgenUnützer, a geriatric psychiatrist
and health services researcher, he published an important observational
study identifying that depression in older primary care patients was as-
sociated with substantial disability and with signiﬁcantly higher
healthcare costs over a 4-year f/u period [35]. The higher costs observed
were primarily the result of increased general medical costs and not
costs related to mental health specialty care. This observational study,
in combination with Dr. Katon's pioneering interventional work,
would lay the foundation for the next iteration of collaborative care.
After completing his fellowship with Dr. Katon, Dr. Unützer contin-
ued to collaborate closely with Dr. Katon et al. on an adaptation of col-
laborative care that would target depression in older adults with
signiﬁcant comorbid medical problems. This adaptation incorporated
into the original collaborative care model a depression care manager,
supervised weekly by a psychiatrist, to deliver behavioral activation
and problem-solving treatment and to facilitate antidepressant man-
agement by PCPs, while systematically tracking patient outcomes in a
Web-based registry [36] and making treatment adjustments if patients
were not improving as expected. This intervention would become
known as the Improving Mood-Promoting Access to Collaborative
Treatment (IMPACT) program and was tested in an RCT with 1801 de-
pressed older adults in 18 primary care clinics in ﬁve states [36]. The
IMPACT programmore than doubled the likelihood that patients expe-
rienced improvement in depression [36], and it was also found to re-
duce functional impairment from arthritis-related pain [37], increase
physical activity and improve physical functioning [38]. More recent
analyses found that intervention patients at one of the IMPACT sites
had signiﬁcantly lower risk of myocardial infarction or strokes in the
years following the intervention [39]. The IMPACT program was also
found to be cost-effective [40,41], returning more than US$6 for each
US$1 spent on the collaborative care intervention.
4. Depression, diabetes and the evolution of team care (2000–2015)
While working with on the IMPACT trial, Dr. Katon became increas-
ingly interested in the adverse effects of comorbid major depression on
diabetes mellitus. This interest was informed by his clinical work pro-
viding psychiatric consultations in a primary care clinic, where depres-
sion and diabetes were highly prevalent. Dr. Katon was joined in this
new avenue of research by Dr. Paul Ciechanowski, a dually trained psy-
chiatrist and PCP, and a fellow in Dr. Katon's T32 training program. In
Table 2
Summary of selected articles authored or coauthored by Wayne Katon reporting important ﬁndings from randomized controlled interventional trials.
Study Setting, population and N
randomized
Intervention tested Outcomes assessed Follow-up
period
(months)
Key ﬁndings
Katon et al. 1992 [21] 251 (intervention = 124,
usual care control = 127)
primary care patients with
high care utilization
Primary care-based psychiatric
consultation:
1. Single psychiatric consultation
in primary care comprised of:
- 1 h consultation with
psychiatrist
- 30 min inperson case review by
psychiatrist with PCP present
- Joint formulation of treatment
plan between psychiatrist and PCP
2. During f/u period, psychiatrist
conferred w/ PCP once to assess
how psychiatric treatment
progressing
1. Depression
2. Anxiety
3. Somatization
4. Disability
5. Healthcare utilization
6, 12 1. Intervention patients were
signiﬁcantly more likely to be prescribed
an antidepressant by 6 month f/u and
were more likely to have ﬁlled ≥3
antidepressant prescriptions by 6 and
12 month f/u.
2. Signiﬁcant increase in antidepressant
prescriptions overall by PCPs receiving
psychiatric consultations.
3. No signiﬁcant effects on symptoms of
depression or anxiety, somatization,
disability or utilization.
Katon et al. 1995 [23] 217 depressed (major
depression = 91, minor
depression = 126) primary
care patients (intervention
= 108, usual care = 109)
from a single primary care
clinic
Multifaceted primary care-based
intervention:
1. At baseline, patients received
informative handouts on
depression, psychotherapy,
“doctor-patient” relationship,
questionnaire on prior
antidepressant side effects and
informative videotape
2. PCPs had a depression training
at baseline, monthly case
conferences and case-by-case
consultation w/ psychiatrists
3. Alternating visits with PCP
(visits 1 and 3) and psychiatrist
(visits 2 and 4) beginning 7 to
10 days postbaseline
4. Psychiatrist reviewed
automated pharmacy data from
3–7 months post-baseline to track
antidepressant adherence
Primary outcomes:
1. 30-day and 90-day
antidepressant use at
guideline doses
2. Patient satisfaction in
depression care
3. Depressive symptoms
1, 4, 7 1. Intervention patients with major
depression were signiﬁcantly more
likely to be adherent to guideline-level
dosed antidepressants for ≥90 days, be
satisﬁed with their depression care, ﬁnd
antidepressants helpful and to have
≥50% reduction in depressive symptoms
at 4 and 7 month f/u.
2. Intervention patients with minor
depression were signiﬁcantly more
likely to be adherent to guideline-level
dosed antidepressants for ≥90 days and
to ﬁnd antidepressants helpful, though
were notmore likely to be satisﬁedwith
depression care or to have signiﬁcant
reduction in depressive symptoms.
Katon et al. 1996 [24] 153 of the 217 depressed
(major depression = 65,
minor depression = 88)
primary care patients
(intervention = 77, usual
care = 76) reported on in
Katon et al. 1995
In addition to elements reported
in Katon et al. 1995, the
following:
1. 4–6 visits with a psychologist
for brief psychotherapy in primary
care with follow-up phone calls at
2, 4, 12, and 24 weeks after ﬁnal
inperson visit
2. Case-by-case consultation
between PCPs with psychologists
on behavioral management of
depression
Primary outcomes:
1. Treatment adherence to
both antidepressants and
psychotherapy visits
2. Patient satisfaction in
depression care
3. Depressive symptoms (4
measures used)
1, 4, 7 1. Intervention patients with major or
minor depression were signiﬁcantly
more likely to be adherent to
antidepressants at 4 month f/u.
2. 88% of intervention patients
completed ≥4 psychotherapy visits.
3. Intervention patients with major
depression had signiﬁcant reduction in
depressive symptoms across all 4
measures, while those with minor
depression only had signiﬁcant
symptom reduction in 1 of 4 measures.
Katon et al. 1999 [26] 228 primary care patients
(intervention = 114, usual
care = 114) from 4
primary care clinics with
persistent depression 6 to
8 weeks after prescription
of an antidepressant by
their PCP
Stepped collaborative care:
1. At baseline, patients received
book on depression outlining
effects of medications and
psychotherapy and informative
videotape to view with partner
2. Two inperson visits with
psychiatrist in primary care clinic
within 4 week period
3. Immediate feedback from
psychiatrist to PCP
4. Psychiatrist reviewed monthly
automated pharmacy data on
antidepressant reﬁlls to track
adherence
Primary outcomes:
1. Patient adherence to
guideline-dosed
antidepressants
2. Patient satisfaction with
depression care
3. Depressive symptoms
1, 3, 6 1. Intervention patients were
signiﬁcantly more likely to adhere to
antidepressants at each f/u time point.
2. Intervention patients were
signiﬁcantly more likely to be satisﬁed
with care of their depression at 3 and
6 month f/u.
3. Intervention patients had signiﬁcant
decline in depressive symptoms at
3 month f/u with nonsigniﬁcant
improvement between 3 and 6 months.
4. Intervention patients signiﬁcantly
more likely to have remission of
depression at 3 and 6 month f/u.
Katon et al. 2001 [27] 386 primary care patients
(intervention = 194, usual
care = 192) with
remission of major
depression or dysthymia
treated with
antidepressants by
their PCP
Collaborative care relapse
prevention program:
1. Patients provided with book
and videotape on recurrent and
chronic depression
2. Two inperson visits in primary
care and telephone f/u with
nonphysician depression
specialist trained by psychiatrist,
psychologist and PCP
3. Visits with depression specialist
Primary outcomes:
1. Adherence to guideline-
dosed antidepressants
2. Depressive symptoms
3. Relapse/Recurrence of
depression episode
3, 6, 9, 12 1. Intervention patients signiﬁcantly
more likely to be adherent to
antidepressant treatment.
2. There was a modest intervention
effect of decreasing depressive
symptoms.
3. There were no signiﬁcant
differences between intervention and
usual care in preventing depressive
episode recurrences.
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Table 2 (continued)
Study Setting, population and N
randomized
Intervention tested Outcomes assessed Follow-up
period
(months)
Key ﬁndings
focused on antidepressant
adherence, enhancing self-efﬁcacy
along with behavioral activation
and problem solving, and
development of personal relapse
prevention plan
Roy-Byrne et al.
2001 [28]
115 primary care patients
with panic disorder from 3
primary care clinics
(intervention = 57, usual
care = 58)
Collaborative care for panic
disorder in primary care:
1. PCPs received lecture on panic
disorder and treatment strategies
2. Initial 1 h evaluation visit with
psychiatrist in primary care clinic
where paroxetine started
3. Informational video on panic
disorder and antidepressants
mailed to patients
4. Psychiatric f/u as follows: week
2: 10–15 min telephone call by
psychiatrist, week 4: 30 minute
inperson visit with psychiatrist,
week 6: 10–15 min telephone call
with psychiatrist, months 3–12: 5
telephone calls with psychiatrist
5. All medication adjustments
made by psychiatrist
Primary outcomes:
1. Panic disorder severity
2. Anxiety sensitivity
3. Depressive symptoms
4. Adherence to guideline-
doses of paroxetine
5. HRQOL
3, 6, 9, 12 1. Intervention patients more likely to
receive adequately-dosed
antidepressants and more likely to be
adherent with medications at 3 and
6-month f/u.
2. Intervention patients had
signiﬁcantly lower panic symptom
severity vs. usual care at 6-month f/u.
3. Intervention patients had
signiﬁcantly lower scores on anxiety
sensitivity measures vs. usual care at
all f/u time points.
4. Intervention patients had
signiﬁcantly fewer depressive
symptoms vs. usual care at all f/u
time points.
5. Intervention patients had
signiﬁcantly better SF-36 role
functioning vs. usual care.
Unützer et al. 2002 [36],
Lin et al. [37]
1801 primary care patients
≥60 years old from 18
primary care clinics
(intervention = 906, usual
care = 895) with major
depression (17%),
dysthymia (30%) or both
(53%)
IMPACT collaborative care
management for late-life
depression:
1. Patients received educational
booklet and videotape about late-
life depression
2. Visits in primary care with
depression care manager (nurse
or psychologist) for 12 months
3. Sessions between patients and
care manager included focus on
medication adherence and PST
4. Depression care manager
reviewed cases weekly with
supervising psychiatrist and
liaison PCP
5. Depression care manager
worked with patient's PCP to
start/adjust antidepressants
6. Stepped care protocol in which
patients who do not improve are
offered inperson psychiatric
consultation
Primary outcomes:
1. Depressive symptoms
2. Depression treatment
response deﬁned as ≥ 50%
decrease in depressive
symptoms from baseline
3. Adherence to
antidepressants and
psychotherapy
4. Patient satisfaction with
depression care
5. Health-related
functional impairment
3, 6, 12 1. At 12 month f/u, intervention
patients were 3.45-times more likely
to have ≥50% decrease in depressive
symptoms from baseline.
2. Depressive symptom severity
was signiﬁcantly lower in
intervention patients vs. usual care
at 12-month f/u.
3. Intervention patients were more
adherent with antidepressants and
reported greater satisfaction with
depression care.
4. Intervention patients had
signiﬁcant improvements in
functioning and HRQOL vs. usual
care, and reported less arthritis-
related pain.
Zatzick et al. 2004 [30] 120 survivors of traumatic
injuries recruited at a Level
I trauma center
(intervention = 59, usual
care = 61)
Stepped collaborative care for
PTSD following traumatic injury:
1. Case management by a master's
level trauma support specialist for
6 months postinjury
2. Trauma support specialist
provided brief intervention
for alcohol misuse in patients
with positive alcohol screens
on admission
3. At 3 months postinjury,
patients with PTSD offered
pharmacotherapy by a
psychiatrist, psychotherapy by a
psychologist or both with ongoing
treatment for 6–12 months
postinjury
4. Weekly case reviews between
trauma support specialist,
psychiatrist and psychologist
Primary outcomes:
1. PTSD symptom severity
2. % meeting criteria for
PTSD diagnosis
3. Alcohol abuse/
dependence
1, 3, 6, 12 1. Intervention patients had
signiﬁcantly lower levels of PTSD
symptoms during f/u.
2. While there was no difference in %
of patients meeting PTSD diagnostic
criteria in the intervention group
during f/u, there was a 6% increase in
patients meeting PTSD diagnostic
criteria in the usual care group.
3. At 6 month f/u, the prevalence of
alcohol abuse/dependence decreased
by 20% in the intervention group vs.
7% in usual care. This effect was
sustained at 12-month f/u.
Katon et al. 2004 [44] 329 patients with diabetes
and comorbid major
depression or dysthymia
from 9 primary care clinics
(intervention = 164, usual
care = 165)
Collaborative care for patients
with diabetes in primary care:
1. Three nurses trained in
collaborative care treatment of
depression and delivery of PST to
work as care managers
Primary outcomes:
1. Depressive symptoms
2. Patient global
assessment of depression
improvement
3. Patient satisfaction with
3, 6, 12 1. Intervention patients had
signiﬁcantly better adherence to
antidepressant medications vs.
usual care.
2. Intervention patients had
signiﬁcant decreases in depressive
(continued on next page)
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Study Setting, population and N
randomized
Intervention tested Outcomes assessed Follow-up
period
(months)
Key ﬁndings
2. Patients offered initial choice of
antidepressant (prescribed by PCP)
or PST (delivered by care manager)
3. Nurse care managers followed
patients twice per month for ﬁrst
3 months
4. Stepped treatment for patients
with persistent depression at
12 weeks including addition of
antidepressant or PST,
antidepressant switch and/or
psychiatric consultation
5. Once patients reached ≥50%
reduction in depressive symptoms,
telephone f/u with nurse care
managers only
6. Nurse care managers supervised
by psychiatrists, psychologist
and PCP
depression care
4. Adherence to
antidepressants
5. HbA1c levels
symptoms over time vs. usual care.
3. Intervention patients were 3.5-
times more likely to have higher
global assessment of depression
improvement ratings at 6 and 12-
month f/u vs. usual care.
4. Intervention patients were
signiﬁcantly more satisﬁed with
depression care vs. usual care.
5. In spite of improvements in
depression, there were no signiﬁcant
differences in HbA1c levels between
intervention vs. usual care patients.
Katon et al. 2010 [53],
Von Korff et al. [55],
Lin et al. [56]
214 patients with diabetes,
CAD, and/or both with
comorbid depression
(intervention = 106, usual
care = 108) from 14
primary care clinics
TEAMcare collaborative care for
patients with depression and
chronic illnesses:
1. Treat-to-target program
targeting depressive symptoms,
HbA1c, blood pressure and lipids
2. Patients work collaboratively
with nurse care managers and
their PCP
3. Patients seen by nurse care
manager every 2–3 weeks in
primary care clinic for depression
and medical condition f/u
4. Nurse care managers trained on
guideline level medication
treatment of depression and
chronic medical conditions and
collaborated with PCPs (who
prescribed medications) on dose
adjustments
5. Maintenance phase after
patients reached treatment target
levels with monthly telephone
calls by nurse care manager
6. Nurse care managers
supervised by psychiatrist,
psychologist and PCP
Primary outcomes:
Simultaneous modeling of
depression, HbA1c, LDL
cholesterol and systolic
blood pressure at
12 months
6, 12 1. Intervention patients had
signiﬁcant decreases in HbA1c, LDL
cholesterol, systolic blood pressure
and depressive symptoms at
12 month f/u vs. usual care.
2. Interventions patients were
signiﬁcantly more likely to have ≥ 1
adjustment in insulin doses,
antihypertensive medications and
antidepressants.
3. Intervention patients had
signiﬁcantly better functioning and
reported signiﬁcantly better HRQOL
vs. usual care.
4. Intervention patients reported
signiﬁcantly greater satisfaction with
care for diabetes, CAD and depression.
Richardson et al.
2014 [65]
101 adolescents ages
13–17 with depression
from 9 primary care clinics
(intervention = 50, usual
care = 51)
Collaborative care for adolescent
depression:
1. Patients received
developmentally sensitive
educational materials and
parental involvement encouraged
2. Care delivered by master’s-level
clinicians (depression care
manager) supervised in weekly
meetings by psychiatrist,
psychologist and pediatrician
3. Medications prescribed by PCP
4. Patients and parents given
initial choice of treatment:
antidepressant, brief CBT
(delivered by depression care
manager) or both
5. Inperson follow-up with
depression care manager every
1–2 weeks until clinical response
(symptom decrease ≥50%) or
remission, then followed by
monthly f/u out to 12 months
6. Patients without response by
8 weeks had stepped increase
in care
Primary outcome:
Change in depressive
symptoms from baseline to
12 month f/u
Secondary outcomes:
1. Functional impairment
2. Clinical response (≥50%
decrease in depressive
symptoms)
3. Depression remission
(PHQ-9≤5)
6, 12 1. Intervention patients had
signiﬁcant decreases in depressive
symptoms by 12-month f/u vs.
usual care.
2. Intervention patients were 3.3-
times more likely to have clinical
response in depression.
3. Intervention patients were 3.9-
times more likely to achieve
remission of depression.
4. There were no signiﬁcant
differences in functional impairment
between intervention and usual
care patients.
Katon et al. 2015 [69] 205 women (120 without
health insurance or with
Women's health-based
collaborative care for depression:
Primary outcomes:
1. Depressive symptoms
6, 12, 18 1. Intervention patients had
signiﬁcant decreases in depressive
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Study Setting, population and N
randomized
Intervention tested Outcomes assessed Follow-up
period
(months)
Key ﬁndings
public health insurance
and 85 with private
health insurance) seen in
2 OB-GYN clinics
(intervention = 102,
usual care = 103)
1. MSW depression care managers
2. Charity care for medications for
uninsured patients
3. Patients met inperson or via
phone with depression care
manager every 1–2 weeks for up
to 12 months, with monthly
contacts once patients had ≥50%
depressive symptom decrease
and/or remission
4. Patient choice of initial
treatment: antidepressant, PST
or both
5. Care manager worked
collaboratively with OB-GYN on
antidepressant prescription and
dose adjustments
6. Stepped care escalation for
patients without response by
8 weeks
7. Care manager supervised by
psychiatrist, psychologist and
OB-GYN
2. Patient-rated global
improvement in
depression
3. Satisfaction with
depression treatment
4. Self-rated quality of
mental healthcare
symptoms and were signiﬁcantly
more likely to have ≥50% reduction in
symptoms as well as be satisﬁed with
their depression care vs. usual care.
2. Effect size of intervention was
signiﬁcantly greater among women
without health insurance or with
public insurance (d = 0.81 at
12 months, d = 0.59 at 18 months)
vs. women with private health
insurance (d = 0.39 at 12 months,
d = 0.23 at 18 months)
Abbreviations (in alphabetical order): CBT = cognitive–behavioral therapy; LDL = low-density lipoprotein; MSW=master's degree in social work; PST = problem-solving therapy.
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search psychologist and statistician at the University of Washington,
authored an important cohort study identifying that depression in pa-
tients with diabetes was independently associatedwithworse glycemic
control, poorer HRQOL and greater healthcare costs [42].
Following up on these ﬁndings, Dr. Katon et al. designed a new co-
hort study that would inform much of what we know about the rela-
tionship of depression and diabetes, the Pathways study [43]. This
study would utilize the Diabetes Registry at Group Health to follow
over 4100 patients with diabetes for 5 years andwould also incorporate
a randomized trial of collaborative care for depression in over 300 of
these patients who had comorbid depression. Dr. Katon and his col-
leagues hypothesized that since depression led to worse adherence to
diabetes treatments [42], treating depression effectively should not
only improve depression-related outcomes but also glycemic control.
In 2004, the results of the Pathways RCT were published in the Ar-
chives of General Psychiatry [44]. Dr. Katon et al. reported that while
an IMPACT model of collaborative care for depression delivered by
clinician-supervised care managers signiﬁcantly improved depression
outcomes in primary care patients with diabetes, it did not signiﬁcantly
improve glycemic control as assessed by glycosylated hemoglobin
(HbA1c) levels [44]. Based on this negative result, the research team
recognized that passive improvement of diabetes by improving depres-
sion alone was not likely to occur and improving diabetes outcomes in
patients with comorbid diabetes and depression would require more
active diabetes-targeted intervention [44]. However, the intervention
was found to be cost-effective for improving depression outcomes
with a net economic beneﬁt of nearly US$1000 per patient treated [45].
Dr. Katon et al. identiﬁed key aspects of the long-termhealth effects of
comorbid depression in patients with diabetes through the Pathways Ep-
idemiologic Study. Seminal ﬁndings from this cohort study included that
comorbid depression in patientswith diabeteswas independently associ-
ated with a greater number of CAD risk factors [46], greater burden of di-
abetes symptoms [47],worse diabetes-treatment adherence and self-care
[48], more long-term diabetes-related microvascular and macrovascular
complications [49] and mortality at 5 and 10-year f/u [50,51].
The lack of effect on diabetes outcomes seen in the Pathways RCT be-
came clearer to the research team in light of what had been learnedabout how to improve outcomes for depression. Synthesizing the ﬁnd-
ings on the impact of comorbid depression on health behaviors in pa-
tients with diabetes from the Pathways Epidemiologic Study as well as
taking stock of potentially key ingredients missing from the interven-
tion tested in the Pathways RCT, Dr. Katon and his research team de-
signed a new multidisciplinary intervention that fully integrated
psychiatric, behavioral science, healthcare systems and primary care in-
tervention strategies. Recognizing that patients with diabetes frequent-
ly have multiple comorbidities, including depression, CAD and
hypertension [52], the team designed an intervention that utilized the
same principles of their prior collaborative care interventions for de-
pression and extended them to diabetesmanagement and CAD risk fac-
tor modiﬁcation. Treat-to-target strategies of enhanced primary care
practice for managing hypertension, poor glycemic and lipid control
and depression were adapted by Dr. Elizabeth Lin for multicondition
case management, while Dr. Evette Ludman adapted behavioral strate-
gies for engaging patients in chronic disease management for use in
multicondition casemanagement. The teamdeveloped new approaches
for efﬁcient supervision of the nurse care managers who delivered the
intervention, focusing supervision on the patientswhowere not achiev-
ing improved outcomes. Healthcare systems strategies of the chronic
care model [20] were fully integrated into the intervention, including
a patient database that tracked nurse care manager contacts with pa-
tients and patient progress toward achieving treatment goals.
This multicondition collaborative care intervention, known as TEAM-
care, was tested in an RCT in 214 primary care patients with poorly con-
trolled diabetesmellitus, CAD or both, in addition to comorbid depression
[53,55,56]. In 2010, Dr. Katon et al. reported in theNewEngland Journal of
Medicine thatmulticondition collaborative care not only signiﬁcantly im-
proved depressive symptoms but also led to lower HbA1c, better blood
pressure control and lower cholesterol levels in intervention patients
compared to usual care [53]. Subsequent reports from the trial identiﬁed
that the interventionwas cost-effective [54], patients had improved func-
tioning [55] and that dose adjustments through the “treat-to-target” in-
tervention were critically important in achieving improvements in
blood pressure, glycemic, lipid and depression outcomes [56]. The
TEAM-care trial was immediately inﬂuential, leading to implementation
efforts across the United States, including a large dissemination and
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Innovation, the COMPASS project, which was advised by Drs. Katon and
Lin on the adaptation of TEAM-care principles to other care settings.
As TEAM-care dissemination was moving forward, Dr. Katon and his
research team continued to focus on important epidemiological work in
the area of depression and diabetes comorbidity. A speciﬁc avenue of ep-
idemiological investigation Dr. Katon focused on during this timewas the
relationship of depression, diabetes and dementia risk. This important
work began with a study using data from 3800 diabetes patients in Path-
ways that found that comorbid major depression was independently as-
sociated with increasing risk of dementia diagnosis [57]. This study was
subsequently followed up with a larger cohort study of over 19,000 pa-
tients with diabetes in Northern California that conﬁrmed the previously
identiﬁed association between comorbidmajor depression and increased
dementia risk [58], aswell as a third study analyzing data from the Action
to Control Cardiovascular Risk in Diabetes trial which found that comor-
bid major depression was associated with increased risk of cognitive de-
cline in patients with diabetes [59]. However, Dr. Katon was interested
in furthering this work by estimating the differential risks conferred by
depression or diabetes on the development of dementia, as well as the
impact of comorbid depression and diabetes on dementia risk among
middle-aged adults. To answer these questions, Dr. Katon reached out
to Dr. Mogens Vestergaard, a Danish PCP and epidemiologist who directs
a research group conducting studies onmental health in primary care set-
tings using data from the massive Danish health registries. In an article
published posthumously in JAMA Psychiatry that reported on research
utilizing data from over 2.4 million Danish adults over age 50, Dr. Katon,
Dr. Dimitry Davydow, a recent T-32 fellow, and their Danish colleagues
found that diabetes alonewas associatedwith 20% greater risk of demen-
tia, depression alone was associated with an over 80% greater risk of de-
mentia and that having both was associated with 107% greater risk [60].
Further, this study found that 25% of all dementia cases in Danish adults
between the ages of 50 and 65were potentially attributable to comorbid-
ity between depression and diabetes [60].
5. Improving depression care for women and children (2004–2015)
Dr. Katon was also inﬂuential in improving access to high-quality
mental healthcare for adolescents andpregnantwomen, twopatient pop-
ulations with particular difﬁculties obtaining needed care. This interest
was sparkedby his collaborationwithDr. Laura Richardson, an adolescent
medicine specialist at the University of Washington. Their initial work
identiﬁed gaps in mental healthcare for youth with Medicaid coverage
in Washington state [61], found increased healthcare utilization and
costs among adolescents with asthma and comorbid depressive and/or
anxiety disorders [62], reported increased health-risk behaviors among
adolescents with depression [63], and validated the Patient Health
Questionnaire-2 (PHQ-2) as a screening instrument for depression in ad-
olescents in primary care settings [64]. These studies informed an RCT of
collaborative care for depressed adolescents in primary care which found
signiﬁcant reductions in depressive symptoms and greater likelihood of
depression remission among those randomized to the intervention [65].
Dr. Katon'swork inmaternalmental healthcarewas spurred by a fel-
low in his T-32 program, Dr. Jennifer Melville, an obstetrician-
gynecologist, as well as by collaboration with social worker and
researcher, Dr. Nancy Grote, both with interests in this area. Important
epidemiological works from these collaborations included a cross-
sectional study documenting a high prevalence of suicidal ideation
among depressed women receiving prenatal care [66] and a meta-
analysis of cohort studies identifying that linked perinatal depression
to a range of adverse birth outcomes, particularly among socioeconom-
ically disadvantagedwomen [67]. These studieswere followed by a suc-
cessful RCT of collaborative care for depression in two obstetrics–
gynecology clinics [68,69] and a third RCT of collaborative care focusing
on improving perinatal depression in socioeconomically disadvantaged
women whose results are forthcoming [70].6. The impact of Wayne Katon's academic work
The work that Dr. Katon and his team conducted have had tremen-
dous inﬂuence on clinical research to improve the care of psychiatric ill-
nesses in primary care and other nonmental health specialty settings.
The results of the initial depression collaborative care trials by Dr. Katon
et al. inﬂuenced a multicenter randomized trial led by Dr. Kenneth
Wells at University of California in Los Angeles, the Depression Patient
Outcomes Research Teamor Partners in Care trial [71]. This study showed
that treatment approaches could be generalized to diverse community
primary care settings with improved long-term outcomes for depressed
patients [71]. At GHRI, Dr. Gregory Simon carried out a successful large
trial of telephonic caremanagement informed by the studies of collabora-
tive care [72]. This study and several subsequent studies by Dr. Simon
et al. at GHRI utilized collaborative care approaches with enhanced efﬁ-
ciency of delivering caremanagement interventions including bothmed-
ication management and psychotherapeutic components [72–74].
In 2002, the US Preventive Services Task Force revised a previous
recommendation against routine screening for depression in primary
care settings, concluding that depression screening could be effective
“when screening is coupled with system changes that help ensure ade-
quate treatment and follow-up,” recognizing that when principles of
collaborative care for depression were applied, improved recognition
of depression in primary care settings could improve patient outcomes
[75]. Subsequently, a 2006 meta-analysis of 37 randomized trials found
the collaborative care approach to be effective in improving depression
outcomes [76], results replicated by a 2012 Cochrane Collaboration sys-
tematic review of 79 trials of collaborative care for depression and anx-
iety disorders [77].Most of the intervention trials of the last decade have
incorporated aspects of the collaborative care work of Dr. Katon and his
research team in order to address depression in several medically ill
populations, including in patients with cardiac disease [78,79], patients
withhuman immunodeﬁciency virus [80], low-incomepatientswith di-
abetes [81] and cancer patients [82–85]. Collaborative care has also been
adapted to improve care of neuropsychiatric symptoms of dementia
[86] and to reduce pain and decrease dependence on opioid analgesics
in primary care patients with chronic pain [87].
Perhaps, the most effective way of conveying the impact of
Dr. Katon's academic work is through the words of his colleagues.
Dr. Michael Sharpe, Professor of Psychological Medicine at Oxford
University and principal investigator of the SMaRTOncology RCTs of col-
laborative care for depression in patients with cancer, observed that,
“Wayne’s work and collaborative care was the basis of our work in can-
cer. His focus onmajor depression as an important but tractable problem
informed the focus of my work and his collaborative care models were
the basis of our depression care system” (personal communication —
Dr.Michael Sharpe). These sentimentswere echoed byDr. Kurt Kroenke,
Professor of Medicine at Indiana University, who said, “In our own col-
laborative trials on pain, and then pain/depression, the seminal work
hugely inﬂuenced us” (personal communication — Dr. Kurt Kroenke),
and by Dr. Jeffrey Huffman, director of the Cardiac Psychiatry Research
Programat theMassachusetts General Hospital, who said, “Wayne inﬂu-
encedmywork—and our team’s work—at every possible step. It was his
work in collaborative care that generated the ideas for both our
SUCCEED and MOSAIC collaborative care studies, and the collaborative
care model used in these settings was adapted for inpatient care but
wholly modeled on his innovative model of care. He was one-of-a-
kind, a real aspirational model for all of us who try to do research that
affects the lives of people with comorbid mental health and medical
conditions” (personal communication — Dr. Jeffrey Huffman).
7. Conclusion
In a career spanning four decades, Dr. Wayne Katon and his research
team revolutionized the care for common psychiatric illnesses such as
depression in primary care settings. Using rigorous epidemiological,
385D.S. Davydow et al. / General Hospital Psychiatry 37 (2015) 375–386health services research and behavioral science research to inform the
development of high-quality interventions such as collaborative care,
Dr. Katon blazed a scholarly trail that is unparalleled in psychosomatic
medicine. The inﬂuence and impact of his work will live on through
his publications and through the generations of investigators that he
personally mentored as well as through mentees of close collaborators
and colleagues. Dr. Katonwas a paragon of scholarship in psychosomat-
icmedicine and psychiatry. His life andwork are epitomized byBessie A.
Stanley's “What is Success?” [88], “To leave the world a bit better,
whether by a healthy child, a garden patch, or a redeemed social condi-
tion; to know that even one life has breathed easier because you have
lived – that is to have succeeded.”
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